Teva Pharmaceutical Indus (TEVA)
51.47
+0.24 +0.47%
NYSE
Sep 23, 20:00
Delayed 2m
USD
View All Key Stats
TEVA Key Stats
| Income Statement | |
| Revenue (TTM) | 19.55B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.50 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.493B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 57.11% |
| Profit Margin (Quarterly) | 5.04% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 2.64% |
| Price and Valuation | |
| Market Cap | 47.04B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 2.355 |
| PE Ratio (TTM) | 34.31 |
| Price to Book Value | 1.773 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.3621 |
| Free Cash Flow (Quarterly) | 788.00M |
| Return on Equity (TTM) | 5.94% |
View All TEVA News
TEVA News
-
WireHeadlineTime (ET)
-
Yahoo09/23 17:25
-
Yahoo09/23 15:21
-
Yahoo09/23 10:16
-
Yahoo09/23 09:33
-
Yahoo09/22 16:06
-
Yahoo09/22 11:17
-
SA Breaking News09/22 08:53
-
MT Newswires09/22 08:39
-
Yahoo09/22 08:01
-
Business Wire09/22 08:00
View All Events
TEVA Events
| Date | Type | Description |
|---|---|---|
| 11/15/2016 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd Third Quarter Earnings Conference Call in 2016 |
| 11/15/2016 | Earnings | Teva Pharmaceutical Industries Ltd Third Quarter Earnings in 2016 Release |
| 08/18/2016 | Dividends | Amount: 0.34, Declared Date: Aug 03 2016, Pay Date: Sep 08 2016 |
| 08/04/2016 08:00 EDT | Misc | Teva Pharmaceutical Industries Ltd Second Quarter Earnings Conference Call in 2016 |
| 08/04/2016 | Earnings | Teva Pharmaceutical Industries Ltd Second Quarter Earnings in 2016 Release |
| 08/02/2016 | Misc | Teva Completes Acquisition of Actavis Generics |
| 05/20/2016 | Dividends | Amount: 0.34, Declared Date: May 09 2016, Pay Date: Jun 07 2016 |
| 05/09/2016 08:00 EST | Misc | Teva Pharmaceutical Industries Ltd First Quarter Earnings Conference Call in 2016 |
| 05/09/2016 | Earnings | Teva Pharmaceutical Industries Ltd First Quarter Earnings in 2016 Release |
| 02/25/2016 | Dividends | Amount: 0.34, Declared Date: Feb 12 2016, Pay Date: Mar 14 2016 |
TEVA Fundamentals
Income Statement View Statement
TEVA Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.tevapharm.com
- Investor Relations URL: http://ir.tevapharm.com/phoenix.zhtml?c=73925&p=irol-irhome
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: November 15, 2016
- Last Earnings Release: August 04, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: August 18, 2016
- Description: Teva Pharmaceutical Industries Ltd develops, produces and markets generic, branded & OTC medicines. Its products include Copaxone, Azilect and Provigil.
TEVA Comparables
EditTEVA Excel Add-In Codes
- Name: =YCI("TEVA","name")
- Description: =YCI("TEVA","description")
- Sector: =YCI("TEVA","sector")
- Industry: =YCI("TEVA","industry")
- Est. Current Fiscal Year End: =YCI("TEVA","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other TEVA Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TEVA Tweets Stocktwits
Advertisement